Health Care Equipment & Services

Convatec Group PLC’s capital markets day boosts shares 5.2%, unveiling “Accelerate” strategy for 6‑8% organic revenue growth and strong investor confidence.

Share purchase plan, new Micro‑Pak contract‑manufacturing deal and regulatory filings highlight Lumos Diagnostics’ strategy to raise capital, expand its product line and accelerate growth in point‑of‑care diagnostics.

Dexcom’s Q2/Q3 2025 earnings reveal steady revenue growth, margin improvement, and robust R&D, but investor sentiment warns of pricing, reimbursement, and competition risks.

Options surge for Clover Health (CLOV) ramps up as investors eye its first‑quarter earnings on May 6. With a 42% jump in call volume, mixed analyst ratings, insider sales and a partnership to empower data, the stock’s near‑$2 price faces a critical …

Boston Scientific shares hit a $61.86 close as investors face a May 4, 2026 litigation deadline—earnings guidance shows upside while institutional selling raises caution.

MedMira Inc. (TSXV) is a health‑care equipment innovator focusing on rapid diagnostic tests. Despite a recent 52‑week low and negative P/E, its cutting‑edge technology offers potential upside for long‑term investors.

VentriPoint Diagnostics Ltd. transforms heart disease diagnosis with 3‑D imaging tech, delivering precise, cost‑effective heart models for clinicians worldwide.

Abbott Laboratories’ $23 billion Exact Sciences deal unlocks a new oncology revenue stream, while its strong diabetes and nutrition businesses keep earnings steady—discover how the acquisition reshapes future growth.

Humana’s stock surged 12% after CMS announced a 2.48% Medicare Advantage payment rise for 2027, boosting revenue prospects and investor confidence.

Elevance Health’s Q1 2026 earnings outlook: modest EPS growth, 1.4 % revenue dip, and a 10 % share jump from a Medicare Advantage payment hike.